Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Allo-PBSC Transplant for Relapsed Leukemia/MDS Post-BMT
NCT00002832Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 1995
- Primary completion
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in acute leukemia, myelodysplastic syndrome (MDS), chronic myeloid leukemia (CML), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 1995; status: completed.
02
Drugs
decitabine
03
Conditions
acute leukemiamyelodysplastic syndrome (MDS)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00002832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002832.